Quest Diagnostics Trading Volume Surges 119.95% to Rank 387th in Liquidity as Stock Slumps 4.47% Amid Strategic Partnerships and Regulatory Uncertainty

On October 1, 2025, Quest Diagnostics (DGX) closed with a trading volume of $0.33 billion, marking a 119.95% increase from the previous day's volume and ranking 387th in terms of liquidity among listed equities. The stock finished the session down 4.47% despite elevated trading activity. Key developments influencing the move included a strategic partnership announcement with a major health insurance provider, which expanded access to its diagnostic services but raised questions about margin pressures due to fixed pricing structures. Regulatory updates from the FDA regarding new clinical trial guidelines also created short-term uncertainty among investors, with analysts noting potential compliance costs for the diagnostics sector.

Recent earnings reports highlighted mixed operational performance, with revenue growth in genetic testing segments offset by declining demand in routine lab services. Analysts emphasized the company's exposure to macroeconomic factors, particularly healthcare policy shifts under the new administration. Institutional trading patterns showed increased short-term positioning, with several large fund managers trimming long positions ahead of earnings season. Market participants are now focused on upcoming guidance from the company's Q3 earnings call, scheduled for mid-October, which could provide clarity on 2026 revenue projections.

To run this backtest accurately, I need a bit more detail: 1. Market universe - Which equity universe should we rank by volume each day (e.g., all U.S. listed stocks, only S&P 500 constituents, China A-shares, etc.)? 2. Execution price assumptions - Buy at today’s close and sell at tomorrow’s close (typical “hold 1 day” definition), or another convention? Any transaction-cost or slippage you want applied? 3. Benchmark (optional) - Would you like the results compared with a benchmark index or ETF? Once I have these points I can lay out the retrieval plan and run the back-test.